SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-064983
Filing Date
2023-11-20
Accepted
2023-11-20 08:05:40
Documents
14
Period of Report
2023-11-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20231117.htm   iXBRL 8-K 50238
2 EX-99.1 tcon-ex99_1.htm EX-99.1 14642
3 GRAPHIC img65184791_0.jpg GRAPHIC 23452
  Complete submission text file 0000950170-23-064983.txt   215713

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20231117_pre.xml EX-101.PRE 9461
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20231117_lab.xml EX-101.LAB 12806
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20231117.xsd EX-101.SCH 2481
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20231117_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 231420783
SIC: 2836 Biological Products, (No Diagnostic Substances)